- জেনেরিক নাম
- Ferric Citrate
- শক্তি
- 1000 mg
- ডোজ ফর্ম
- Tablet
- প্রস্তুতকারক
- Square Pharmaceuticals PLC.
৳ ২৪.৫ ৳ ২৫.০০ ২% ছাড় প্রতি ইউনিট
দাম হালনাগাদ: ১৮ Nov ২০২৬
বাংলাদেশে Revocit 1000 mg Tablet ট্যাবলেট হিসেবে পাওয়া যায়; এতে Ferric Citrate আছে (১০০০ mg)। এটি তৈরি করে Square Pharmaceuticals PLC। Ferric Citrate-এর অন্য ব্র্যান্ডগুলো এই পাতায় কম দাম থেকে সাজানো আছে, দাম তুলনা করতে পারবেন। ডাক্তারের প্রেসক্রিপশন মেনে চলুন এবং অন্য ব্র্যান্ড খাওয়া যাবে কি না তা ফার্মাসিস্টের কাছ থেকে জেনে নিন।
Ferric Citrate-এর ৪টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। ইউনিট দামের হিসেবে Revocit এগুলোর মধ্যে সবচেয়ে কম দামিদের একটি।
Revocit 1000 mg Tablet is an oral iron preparation containing ferric citrate. It is used in adults with chronic kidney disease for two purposes: to control serum phosphorus levels in patients on dialysis, and to treat iron deficiency anemia in patients not on dialysis. Ferric citrate works by binding phosphate in the gut and by providing iron that the body can absorb. Common side effects include discolored feces, diarrhea, constipation, nausea, vomiting, cough, abdominal pain, and high potassium levels. The dose is decided by the doctor based on individual needs and monitoring.
Revocit 1000 mg Tablet is used in adults with chronic kidney disease. In patients on dialysis, it helps control serum phosphorus levels by binding phosphate in the digestive tract. In patients not on dialysis, it is used to treat iron deficiency anemia by providing iron. It is not for use in people with iron overload syndromes. The doctor determines whether this medicine is appropriate based on the patient's condition and test results.
Revocit 1000 mg Tablet is taken by mouth with meals. The exact dose and how often to take it are decided by the doctor, who may adjust it based on blood test results and the patient's response. Swallow the tablet whole with water. Do not change the dose without medical advice. If a dose is missed, ask the doctor or pharmacist what to do. Follow the doctor's instructions carefully and attend regular check-ups.
Common side effects of Revocit 1000 mg Tablet include discolored feces, diarrhea, constipation, nausea, vomiting, cough, abdominal pain, and high potassium levels (hyperkalemia). These side effects were reported in at least 5% of patients in studies. Not everyone experiences them. If any side effect bothers you or does not go away, tell your doctor or pharmacist. Do not stop taking the medicine without medical advice.
Before starting Revocit 1000 mg Tablet, tell your doctor if you have iron overload syndromes, as the medicine is not suitable for people with this condition. Your doctor will check iron levels before and during treatment because iron absorption may lead to excessive iron stores. The medicine may interact with other drugs, so tell your doctor about all medicines you take. There are no data on its use in pregnancy or breastfeeding; ask your doctor if you are pregnant, planning pregnancy, or breastfeeding. Keep out of reach of children and store below 30°C, away from light and moisture.
Revocit 1000 mg Tablet is an oral iron preparation containing ferric citrate. It is used in adults with chronic kidney disease to control serum phosphorus levels in patients on dialysis and to treat iron deficiency anemia in patients not on dialysis. It is not for people with iron overload syndromes.
Revocit comes as a tablet, which is a solid dosage form taken by mouth. The strength is 1000 mg, meaning each tablet contains 1000 mg of ferric citrate. The tablet is available in a pack of 5 x 6 tablets. The doctor decides how many tablets you take and for how long.
Revocit may interact with other medicines. Your doctor may need to separate the timing of administration or monitor your response or blood levels of other medications. Tell your doctor or pharmacist about all medicines you take, including prescription and over-the-counter drugs, before starting Revocit.
The listed price is ৳ ২৫.০০. For the most up-to-date price and availability, check the website or ask your pharmacist.
৳ ২৪.৫ ৳ ২৫.০০ ২% ছাড় প্রতি ইউনিট
দাম হালনাগাদ: ১৮ Nov ২০২৬
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Ferric Citrate is a phosphate binder indicated for the control of serum phosphorus levels in adult patients with chronic kidney disease on dialysis. Ferric Citrate is an iron replacement product indicated for the treatment of iron deficiency anemia in adult patients with chronic kidney disease not on dialysis.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Hyperphosphatemia in chronic kidney disease on dialysis: Ferric iron binds dietary phosphate in the GI tract and precipitates as ferric phosphate. This compound is insoluble and is excreted in the stool. By binding phosphate in the GI tract and decreasing absorption, ferric citrate lowers the phosphate concentration in the serum.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Hyperphosphatemia in chronic kidney disease on dialysis:এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
When clinically significant drug interactions are expected, consider separation of the timing of administration. Consider monitoring clinical responses or blood levels of the concomitant medication.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Ferric Citrate is contraindicated in patients with iron overload syndromes.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Most common adverse reactions (incidence ≥5%) are discolored feces, diarrhea, constipation, nausea, vomiting, cough, abdominal pain, and hyperkalemia.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
There are no available data on Ferric Citrate use in pregnant women to inform a drug-associated risk of major birth defects and miscarriage. There are no human data regarding the effect of Ferric Citrate in human milk, the effects on the breastfed child, or the effects on milk production.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Iron absorption from Ferric Citrate may lead to excessive elevations in iron stores. Increases in serum ferritin and transferrin saturation (TSAT) levels were observed in clinical trials. In a 56-week safety and efficacy trial evaluating the control of serum phosphate levels in patients with chronic kidney disease on dialysis in which concomitant use of intravenous iron was permitted, 55 (19%) of patients treated with Ferric Citrate had a ferritin level >1500 ng/mL as compared with 13 (9%) of patients treated with active control. Assess iron parameters (e.g., serum ferritin and TSAT) prior to initiating Ferric Citrate and monitor iron parameters while on therapy. Patients receiving intravenous iron may require a reduction in dose or discontinuation of intravenous iron therapy.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
No data are available regarding overdose of Ferric Citrate in patients. In patients with chronic kidney disease, the maximum dose studied was 2,520 mg ferric iron (12 tablets of Ferric Citrate) per day. Iron absorption from Ferric Citrate may lead to excessive elevations in iron stores, especially when concomitant intravenous iron is used.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।
ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।